CRISPR/Cas9-mediated ASXL1 mutations in U937 cells disrupt myeloid differentiation.
Int J Oncol
; 52(4): 1209-1223, 2018 Apr.
Article
in En
| MEDLINE
| ID: mdl-29532865
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Repressor Proteins
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Leukemia, Myelomonocytic, Chronic
/
Mutation
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Int J Oncol
Journal subject:
NEOPLASIAS
Year:
2018
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Grecia